Found: 34
Select item for more details and to access through your institution.
Anaplastic thyroid cancer: A review of recent evidence and summary of an Australian institutional protocol.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2024, v. 20, n. 6, p. 681, doi. 10.1111/ajco.14106
- By:
- Publication type:
- Article
Outcomes of SDHB Pathogenic Variant Carriers.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 9, p. 2400, doi. 10.1210/clinem/dgae233
- By:
- Publication type:
- Article
Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus Is Characterized by C-peptide Loss and Pancreatic Atrophy.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 5, p. 1301, doi. 10.1210/clinem/dgad685
- By:
- Publication type:
- Article
Response to Letter to the Editor From Devgan and Mayilvaganan: "Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma".
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 1, p. e437, doi. 10.1210/clinem/dgad380
- By:
- Publication type:
- Article
Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 10, p. 2626, doi. 10.1210/clinem/dgad173
- By:
- Publication type:
- Article
Selpercatinib Treatment of RET-Mutated Thyroid Cancers Is Associated With Gastrointestinal Adverse Effects.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 9, p. e3824, doi. 10.1210/clinem/dgac337
- By:
- Publication type:
- Article
Association of Antithyroid Antibodies in Checkpoint Inhibitor–Associated Thyroid Immune–Related Adverse Events.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 5, p. 1843, doi. 10.1210/clinem/dgac059
- By:
- Publication type:
- Article
Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes”.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2020, v. 105, n. 6, p. e2317, doi. 10.1210/clinem/dgaa144
- By:
- Publication type:
- Article
Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes”.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2020, v. 105, n. 6, p. e2317, doi. 10.1210/clinem/dgaa144
- By:
- Publication type:
- Article
Response to Letter to the Editor: "Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes".
- Published in:
- 2020
- By:
- Publication type:
- Letter
Checkpoint Inhibitor–Associated Autoimmune Diabetes Is Distinct From Type 1 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2019, v. 104, n. 11, p. 5499, doi. 10.1210/jc.2019-00423
- By:
- Publication type:
- Article
Australasian Consensus Statement on the Identification, Prevention, and Management of Hormonal Crises in Patients with Neuroendocrine Neoplasms Undergoing Peptide Receptor Radionuclide Therapy.
- Published in:
- Neuroendocrinology, 2023, v. 113, n. 3, p. 281, doi. 10.1159/000526848
- By:
- Publication type:
- Article
Correction to: Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 12, p. 7520, doi. 10.1245/s10434-021-10146-3
- By:
- Publication type:
- Article
Fall in thyroid stimulating hormone (TSH) may be an early marker of ipilimumab-induced hypophysitis.
- Published in:
- Pituitary, 2018, v. 21, n. 3, p. 274, doi. 10.1007/s11102-018-0866-6
- By:
- Publication type:
- Article
Challenges and Strategies to Combat Resistance Mechanisms in Thyroid Cancer Therapeutics.
- Published in:
- Thyroid, 2023, v. 33, n. 6, p. 682, doi. 10.1089/thy.2022.0704
- By:
- Publication type:
- Article
Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral Lymphadenopathy.
- Published in:
- Thyroid, 2022, v. 32, n. 9, p. 1086, doi. 10.1089/thy.2022.0109
- By:
- Publication type:
- Article
Thyroid Toxicity Following Immune Checkpoint Inhibitor Treatment in Advanced Cancer.
- Published in:
- Thyroid, 2020, v. 30, n. 10, p. 1458, doi. 10.1089/thy.2020.0032
- By:
- Publication type:
- Article
Editorial: Decoding checkpoint inhibitor-induced immune-related adverse events, volume II.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1317220
- By:
- Publication type:
- Article
Molecular Markers Guiding Thyroid Cancer Management.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2164, doi. 10.3390/cancers12082164
- By:
- Publication type:
- Article
The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma.
- Published in:
- European Journal of Endocrinology, 2018, v. 178, n. 2, p. 175, doi. 10.1530/EJE-17-0810
- By:
- Publication type:
- Article
Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside.
- Published in:
- Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.764138
- By:
- Publication type:
- Article
The utility of cross‐sectional imaging in the management of suspected scaphoid fractures.
- Published in:
- Journal of Medical Radiation Sciences, 2019, v. 66, n. 1, p. 30, doi. 10.1002/jmrs.302
- By:
- Publication type:
- Article
Predicting distant metastatic disease in differentiated thyroid cancer: a matched case–control study.
- Published in:
- ANZ Journal of Surgery, 2021, v. 91, n. 4, p. 716, doi. 10.1111/ans.16652
- By:
- Publication type:
- Article
Immune Related Adverse Events of the Thyroid – A Narrative Review.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.886930
- By:
- Publication type:
- Article
Checkpoint Inhibitor-Associated Autoimmune Diabetes Is Distinct From Type 1 Diabetes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Hypercalcemia in Glucagon Cell Hyperplasia and Neoplasia (Mahvash Syndrome): A New Association.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Risk Factors and Characteristics of Checkpoint Inhibitor–Associated Autoimmune Diabetes Mellitus (CIADM): A Systematic Review and Delineation From Type 1 Diabetes.
- Published in:
- Diabetes Care, 2023, v. 46, n. 6, p. 1292, doi. 10.2337/dc22-2202
- By:
- Publication type:
- Article
Neuroendocrine neoplasms.
- Published in:
- Endocrinology Today, 2024, v. 13, n. 2, p. 6
- By:
- Publication type:
- Article
Thyroiditis: Differentiating the cause.
- Published in:
- Endocrinology Today, 2023, v. 12, n. 3, p. 25
- By:
- Publication type:
- Article
Papillary thyroid microcarcinoma: Is active surveillance always enough?
- Published in:
- Clinical Endocrinology, 2021, v. 95, n. 6, p. 811, doi. 10.1111/cen.14529
- By:
- Publication type:
- Article
Risk factors for development of diabetes mellitus (Type 3c) after partial pancreatectomy: A systematic review.
- Published in:
- Clinical Endocrinology, 2020, v. 92, n. 5, p. 396, doi. 10.1111/cen.14168
- By:
- Publication type:
- Article
Clinical and Molecular Characterization of a Novel PLIN1 Frameshift Mutation Identified in Patients With Familial Partial Lipodystrophy.
- Published in:
- Diabetes, 2015, v. 64, n. 1, p. 299, doi. 10.2337/db14-0104
- By:
- Publication type:
- Article